Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction

American Heart Journal

Volumn 163, Issue 4, 2012, Pages 720-728

  Fosbol, Emil L ^a   Wang, Tracy Y ^a   Li, Shuang ^a   Piccini, Jonathan P ^a   Lopes, Renato D ^a   Shah, Bimal ^a   Mills, Roger M ^b   Klaskala, Winslow ^b   Alexander, Karen P ^a   Thomas, Laine ^a   Roe, Matthew T ^a   Peterson, Eric D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; WARFARIN;

AGED; AGED HOSPITAL PATIENT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; CAUSE OF DEATH; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; STROKE; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ASPIRIN; ATRIAL FIBRILLATION; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; MALE; MEDICARE; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; TICLOPIDINE; TREATMENT OUTCOME; UNITED STATES; WARFARIN;

EID: 84862776576     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.01.017     Document Type: Article

References (42)

1. K.M. Flegel, M.J. Shipley, and G. Rose Risk of stroke in non-rheumatic atrial fibrillation Lancet 1 1987 526 529
2. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 354
3. D.E. Singer, G.W. Albers, and J.E. Dalen Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition) Chest 133 2008 546S 592S
4. D.E. Singer, Y. Chang, and M.C. Fang The net clinical benefit of warfarin anticoagulation in atrial fibrillation Ann Intern Med 151 2009 297 305
5. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) Circulation 106 2002 1893 1900
6. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
7. S. Connolly, J. Pogue, and R. Hart Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial Lancet 367 2006 1903 1912
8. A.S. Go, E.M. Hylek, and Y. Chang Anticoagulation therapy for stroke prevention in atrial fibrillation: How well do randomized trials translate into clinical practice? JAMA 290 2003 2685 2692
9. R.G. Hart, L.A. Pearce, and M.I. Aguilar Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation Ann Intern Med 147 2007 590 592
10. R.D. Lopes, A. Starr, and C.F. Pieper Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes Am J Med 123 2010 134 140
11. G.Y. Lip, K. Huber, and F. Andreotti Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: Executive summary-a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
12. A. Rubboli, J.L. Halperin, and K.E. Airaksinen Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation Ann Med 40 2008 428 436
13. N.K. Choudhry, G.M. Anderson, and A. Laupacis Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis BMJ 332 2006 141 145
14. N.K. Choudhry, S.B. Soumerai, and S.L. Normand Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics Am J Med 119 2006 607 615
15. T.Y. Wang, L.A. Robinson, and F.S. Ou Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry Am Heart J 155 2008 361 368
16. D.P. Faxon, J.W. Eikelboom, and P.B. Berger Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary Circ Cardiovasc Interv 4 2011 522 534
17. R.D. Lopes, L.E. Elliott, and H.D. White Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: Results from the APEX-AMI trial Eur Heart J 30 2009 2019 2028
18. J.W. Hoekstra, C.V. Pollack Jr., and M.T. Roe Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative Acad Emerg Med 9 2002 1146 1155
19. B.G. Hammill, A.F. Hernandez, and E.D. Peterson Linking inpatient clinical registry data to medicare claims data using indirect identifiers Am Heart J 157 2009 995 1000
20. R.A. Kokotailo, and M.D. Hill Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10 Stroke 36 2005 1776 1781
21. Y. Kiyota, S. Schneeweiss, and R.J. Glynn Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: Estimating positive predictive value on the basis of review of hospital records Am Heart J 148 2004 99 104
22. E. Birman-Deych, A.D. Waterman, and Y. Yan Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors Med Care 43 2005 480 485
23. B.F. Gage, A.D. Waterman, and W. Shannon Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
24. S. Subherwal, R.G. Bach, and A.Y. Chen Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the ACC/AHA guidelines) bleeding score Circulation 119 2009 1873 1882
25. M.T. Roe, A.Y. Chen, and L. Thomas Predicting long-term mortality in older patients following non-ST-elevation myocardial infarction-the CRUSADE long-term mortality model Am Heart J 162 2011 875 883
26. O.D. Pedersen, P. Sondergaard, and T. Nielsen Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure Eur Heart J 27 2006 2866 2870
27. O.D. Pedersen, S.Z. Abildstrom, and M.M. Ottesen Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction Eur Heart J 27 2006 290 295
28. J.S. Paikin, D.S. Wright, and M.A. Crowther Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents Circulation 121 2010 2067 2070
29. A. Rubboli Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting World J Cardiol 2 2010 64 67
30. Anticoagulation in stent intervention (MUSICA-2) ClinicalTrials.gov Web site. Available at: http://clinicaltrials.gov/ct2/show/NCT01141153?term= NCT01141153&rank=1 Last accessed January 20, 2012
31. Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation (ISAR-TRIPLE) ClinicalTrials.gov Web site. Available at: http://clinicaltrials.gov/ct2/show/NCT00776633?term=NCT00776633&rank=1 Last accessed January 20, 2012
32. W. Dewilde, and J.T. Berg Design and rationale of the WOEST trial: what is the optimal antiplatelet and anticoagulant therapy in patients with oral anticoagulation and coronary stenting (WOEST) Am HeartJ 158 2009 713 718
33. H.J. Lin, P.A. Wolf, and M. Kelly-Hayes Stroke severity in atrial fibrillation. The Framingham study Stroke 27 1996 1760 1764
34. H.T. Tu, B.C. Campbell, and S. Christensen Pathophysiological determinants of worse stroke outcome in atrial fibrillation Cerebrovasc Dis 30 2010 389 395
35. R. Sorensen, M.L. Hansen, and S.Z. Abildstrom Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
36. M.L. Hansen, R. Sorensen, and M.T. Clausen Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
37. S.G. Johnson, K. Rogers, and T. Delate Outcomes associated with combined antiplatelet and anticoagulant therapy Chest 133 2008 948 954
38. T.I. Shireman, P.A. Howard, and T.F. Kresowik Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients Stroke 35 2004 2362 2367
39. C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 982
40. M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
41. J.L. Mega, E. Braunwald, and S.D. Wiviott Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
42. J.H. Alexander, R.D. Lopes, and S. James Apixaban with antiplatelet therapy after acute coronary syndrome N Engl J Med 365 2011 699 708